You are here

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2025

AbstractFullPdf
Nov 2020363051
Dec 202066010
Jan 2021164024
Feb 2021134013
Mar 2021132034
Apr 202188023
May 202134015
Jun 20210017
Jul 20210015
Aug 20210016
Sep 20210016
Oct 202168014
Nov 202190024
Dec 20213608
Jan 202254014
Feb 202244012
Mar 2022104017
Apr 2022124014
May 202285023
Jun 202278012
Jul 2022123010
Aug 202298012
Sep 202255022
Oct 20225006
Nov 20224005
Dec 20224109
Jan 202356019
Feb 202365011
Mar 202361011
Apr 202366013
May 202354011
Jun 20238005
Jul 202332016
Aug 20236007
Sep 20234608
Oct 20236408
Nov 202377013
Dec 202310408
Jan 20244607
Feb 20245604
Mar 202468014
Apr 20245407
May 20247206
Jun 20247706
Jul 20247007
Aug 20245408
Sep 202410904
Oct 2024102018
Nov 2024120012
Dec 2024102011
Jan 202586027
Feb 202538014
Mar 20252014
Apr 20250012
May 20250013
Jun 20251017
Sep 2025100
Total38940767